Recent 8-K filings for GYRO
Highest-materiality recent filing
Gyrodyne signs agreement to sell 49-acre parcel for up to $28.74M; NAV per share rises to $14.83
- Purchase price range $24M-$28.74M, estimated final price $28.74M; buyer B2K Smithtown LLC.
- Estimated NAV as of June 30, 2025: $32.6M ($14.83/share), up 6% from Q1 NAV of $30.8M ($14.01).
-
Second Amendment provides $1,520,222 credit to B2K for on-site improvements on Lots 1 and 3 of Flowerfield.
-
Gyrodyne LLC announces shareholder voting results from 2025 annual meeting
Richard B. Smith elected as director with 1,394,282 votes for and 29,759 withheld.
-
Gyrodyne CEO provides operational update; Flowerfield parcel sale for $28.74M targeted end of 2027
Sold 49 undeveloped acres of Flowerfield to B2K Development for $28.74M; close expected end 2027 subject to litigation & approvals.
-
Gyrodyne settles with Star Equity; board reduced to four, Star Equity withdraws nominations
Star Equity withdraws June 4, 2025 board nominations; board size cut from five to four.
-
Gyrodyne signs agreement to sell 49-acre parcel for up to $28.74M; NAV per share rises to $14.83
Purchase price range $24M-$28.74M, estimated final price $28.74M; buyer B2K Smithtown LLC.
-
NY Supreme Court dismisses Article 78 petition against Gyrodyne's Flowerfield subdivision approval
On October 11, 2024, the NY Supreme Court ruled in favor of Gyrodyne, dismissing the Article 78 petition challenging the 8-lot subdivision of its Flowerfield property.
-
Gyrodyne LLC reports 2024 annual meeting voting results
Director Ronald J. Macklin elected with 1,030,041 for, 325,673 withheld, and 585,051 broker non-votes.
-
Rights offering oversubscribed 65%, net proceeds $4.4M to defend Article 78 litigation and negotiate from strength.
-
Gyrodyne closes oversubscribed rights offering, raises $5M gross
Gross proceeds of $5M from sale of 625,000 shares at $8 per share; net proceeds ~$4.4M.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.60 · Most common event other_material